Barely Significant
← all excerpts

Therapeutic potential of FGF19 in combatting osteosarcopenia: effects on muscle strength and bone health in aged male mice.

JBMR Plus · 2025 · PMC12579926 · PMID 41185883

Europe PMCDOI
1
hedged sentence
0.0648
closest p · 1.3× alpha
0.0648
boldest claim

The sentences

did not reach statistical significancep = .0648so close (0.05 < p ≤ 0.1)
A decrease in active osteoclastic surface (Oc.S/BS) in the FGF19 treatment group was noted, although it did not reach statistical significance ( p = .0648), even if osteoclast number over bone surface (Oc.N/BS, 1/μm) was actually higher in the FGF19 group ( p = .001; vehicle group: median: 3.63, min-max: 3.19-4.49, mean: 3.72, standard error of the mean: 0.10; FGF19 group: median: 4.64, min-max 4.10-10.43, mean: 5.59, standard error of the mean: 0.58).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.